1. Home
  2. VCYT vs BBU Comparison

VCYT vs BBU Comparison

Compare VCYT & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • BBU
  • Stock Information
  • Founded
  • VCYT 2006
  • BBU 2016
  • Country
  • VCYT United States
  • BBU Bermuda
  • Employees
  • VCYT N/A
  • BBU N/A
  • Industry
  • VCYT Medical Specialities
  • BBU Engineering & Construction
  • Sector
  • VCYT Health Care
  • BBU Consumer Discretionary
  • Exchange
  • VCYT Nasdaq
  • BBU Nasdaq
  • Market Cap
  • VCYT 2.8B
  • BBU 2.4B
  • IPO Year
  • VCYT 2013
  • BBU N/A
  • Fundamental
  • Price
  • VCYT $36.80
  • BBU $35.30
  • Analyst Decision
  • VCYT Buy
  • BBU Buy
  • Analyst Count
  • VCYT 10
  • BBU 6
  • Target Price
  • VCYT $40.40
  • BBU $34.67
  • AVG Volume (30 Days)
  • VCYT 788.0K
  • BBU 96.3K
  • Earning Date
  • VCYT 11-04-2025
  • BBU 11-06-2025
  • Dividend Yield
  • VCYT N/A
  • BBU 0.71%
  • EPS Growth
  • VCYT N/A
  • BBU N/A
  • EPS
  • VCYT 0.34
  • BBU N/A
  • Revenue
  • VCYT $479,129,000.00
  • BBU $30,103,000,000.00
  • Revenue This Year
  • VCYT $14.48
  • BBU N/A
  • Revenue Next Year
  • VCYT $9.79
  • BBU $5.85
  • P/E Ratio
  • VCYT $109.69
  • BBU N/A
  • Revenue Growth
  • VCYT 19.91
  • BBU N/A
  • 52 Week Low
  • VCYT $22.61
  • BBU $18.63
  • 52 Week High
  • VCYT $47.32
  • BBU $36.72
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 62.00
  • BBU 63.63
  • Support Level
  • VCYT $34.38
  • BBU $33.35
  • Resistance Level
  • VCYT $37.07
  • BBU $35.81
  • Average True Range (ATR)
  • VCYT 1.23
  • BBU 1.41
  • MACD
  • VCYT -0.06
  • BBU -0.22
  • Stochastic Oscillator
  • VCYT 90.96
  • BBU 68.23

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

Share on Social Networks: